Newsletter | October 3, 2008

10.3.08 -- Drug Discovery Research Turns To Biomarkers
This Newsletter Is Sponsored By:

Click on logo for more information

Top News Stories
InhibOx And The National Foundation For Cancer Research Launch Powerful Computational Drug Screening Tool
The National Foundation for Cancer Research (NFCR), a Bethesda-based leading cancer research charity in the US, and InhibOx, a computational drug discovery company located in Oxford, UK, announced recently that they have joined forces to launch a powerful new computational drug screening tool, DrugFinder...

Southern Research Institute Launches Consulting Company To Advance Scientific Innovation Through Biosafety And Health Risk Management
Southern Research Institute recently announced the creation of BioSafety Solutions LLC (BSL), a consulting company that will provide services ranging from technical and operational support for existing biosafety and biosecurity programs, to the development and implementation of comprehensive programs for high containment laboratories and organizations involved in life science research and development...

Sun Pharma Chooses FEI Solution For Nanoparticle Research At Advanced Centre In India
FEI Company, a leading provider of high-resolution imaging and analysis systems, announced recently the installation of a solution based upon FEI's Tecnai Spirit cryo-transmission electron microscope (TEM) and three-dimensional (3D) tomography software at Sun Pharmaceutical Industries, Ltd...

ACADIA Pharmaceuticals To Present At The JMP Securities Healthcare Focus Conference On October 6, 2008
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the JMP Securities Healthcare Focus Conference on Monday, October 6, 2008, at 1:00 p.m...

RainDance Technologies Signs A Collaboration Agreement With Sanofi-Aventis And Louis Pasteur University To Launch dScreen Consortium Within ALSACE BIOVALLEY Cluster
RainDance Technologies announced recently the launch of the dScreen Consortium, a research initiative conducted with sanofi-aventis, Paris , and Louis Pasteur University of Strasbourg, France, to develop the next generation of high-throughput screening (HTS) for drug discovery applications...

National Cancer Institute Selects CambridgeSoft To Support Chemical Biology Consortium
The National Cancer Institute has selected the ChemBioOffice Enterprise suite as the single solution Informatics platform to support a highly collaborative drug discovery partnership, the Chemical Biology Consortium...

TEMIS Text Analytics Solution Luxid For Automated Knowledge Discovery In Pharma Research
The strong emphasis that TEMIS, the leading provider of Text Analytics solutions, has put on the Life Science market since many years has led to another important licensing agreement...

Drug Discovery Research Turns To Biomarkers
The total drug discovery market in Western Europe was worth $17.40 billion in 2007, and Frost & Sullivan expects this to grow at a compound annual growth rate of 13.5% to reach $42.08 billion by 2014...

Critical Outcome Technologies Inc. To Advance HIV-1 Integrase Inhibitor Program With A Major Pharmaceutical Company
Critical Outcome Technologies Inc. , announced recently that it has entered into an agreement with a major pharmaceutical company to advance up to six drug candidates from COTI's HIV-1 integrase inhibitor program, identified using its CHEMSAS drug discovery process...

Featured Products
EZ-Bio Personal Evaporator
The EZ-Bio uses advanced and proven technology in evaporation science to solve the common problems of solvent removal in Life Science. The new EZ-Bio Personal Evaporator is all a rugged and modern centrifugal evaporator should be and more.

Enzyme Kinetics Module- SigmaPlot®
The Enzyme Kinetics Module runs seamlessly with SigmaPlot. You can easily create custom reports of your results including tables and graphs, incorporate your graphs into presentations or export your graphs to a wide range of graphic file formats to send it for publishing in journals.

Newsletter Subscription
If you do not currently receive the Drug Discovery Online newsletter and wish to become a subscriber, click here.
Advertise Online
If you are interested in advertising with Drug Discovery Online, click here for more information.